Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress
Open Access
- 30 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (15) , 8665-8683
Abstract
The protein kinase ATR plays pivotal roles in DNA repair, cell cycle checkpoint engagement and DNA replication. Consequently, ATR inhibitors (ATRi) are in clinical development for the treatment of cancers, including tumours harbouring mutations in the related kinase ATM. However, it still remains unclear which functions and pathways dominate long-term ATRi efficacy, and how these vary between clinically relevant genetic backgrounds. Elucidating common and genetic-background specific mechanisms of ATRi efficacy could therefore assist in patient stratification and pre-empting drug resistance. Here, we use CRISPR–Cas9 genome-wide screening in ATM-deficient and proficient mouse embryonic stem cells to interrogate cell fitness following treatment with the ATRi, ceralasertib. We identify factors that enhance or suppress ATRi efficacy, with a subset of these requiring intact ATM signalling. Strikingly, two of the strongest resistance-gene hits in both ATM-proficient and ATM-deficient cells encode Cyclin C and CDK8: members of the CDK8 kinase module for the RNA polymerase II mediator complex. We show that Cyclin C/CDK8 loss reduces S-phase DNA:RNA hybrid formation, transcription-replication stress, and ultimately micronuclei formation induced by ATRi. Overall, our work identifies novel biomarkers of ATRi efficacy in ATM-proficient and ATM-deficient cells, and highlights transcription-associated replication stress as a predominant driver of ATRi-induced cell death.Keywords
Funding Information
- Cancer Research UK (C6/A18796, C6946/A24843)
- Wellcome Investigator Award (206388/Z/17/Z)
- Wellcome Trust (WT203144)
- AstraZeneca
- BBSRC (BB/R50533X/1)
This publication has 90 references indexed in Scilit:
- CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon ResponseImmunity, 2013
- R Loops: From Transcription Byproducts to Threats to Genome StabilityMolecular Cell, 2012
- ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand BreaksCell, 2010
- CDK8 is a positive regulator of transcriptional elongation within the serum response networkNature Structural & Molecular Biology, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA BreaksMolecular Cell, 2009
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- CDK8 Is a Stimulus-Specific Positive Coregulator of p53 Target GenesMolecular Cell, 2007
- ATR‐dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stallingThe EMBO Journal, 2006
- ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaksThe EMBO Journal, 2006